For veterinarians and pet owners navigating the complexities of canine endocrinology, the low dose dexamethasone suppression test (LDDST) remains a pivotal diagnostic tool. This specific biochemical assay is designed to assess the integrity of the hypothalamic-pituitary-adrenal (HPA) axis, primarily to screen for hyperadrenocorticism, or Cushing's disease, in dogs. The test leverages the powerful synthetic glucocorticoid dexamethasone to meticulously observe how a healthy canine body responds by suppressing its own cortisol production, a response that often falters in affected animals.
Understanding the Physiology Behind the Test
The fundamental principle of the LDDST hinges on the negative feedback loop inherent to the HPA axis. In a healthy dog, the administration of a low dose of dexamethasone should signal the brain's hypothalamus and pituitary gland to halt the production of adrenocorticotropic hormone (ACTH). Consequently, the adrenal glands cease their cortisol secretion, leading to a significant drop in circulating cortisol levels by a specific timeframe post-injection. When this suppression fails to occur, it strongly indicates that the adrenal glands are operating autonomously, a hallmark characteristic of Cushing's disease.
Clinical Indications and Veterinary Rationale
Veterinarians typically recommend the LDDST when a dog presents with a constellation of non-specific clinical signs that raise suspicion for hyperadrenocorticism. These signs often include polyuria and polydipsia, unexplained panting, abdominal distension resembling a pot belly, muscle wasting, and fragile skin that bruises easily. Because these symptoms overlap with other conditions, the test provides a relatively accessible and cost-effective method to differentiate Cushing's disease from other systemic illnesses before proceeding to more advanced imaging or definitive testing.
Procedure and Protocol Details
The execution of the LDDST follows a strict protocol to ensure accurate results, requiring meticulous attention to timing and sample collection. The procedure generally involves the following steps:
Baseline blood sample is collected prior to injection.
A low dose of dexamethasone is administered intravenously or intramuscularly.
Subsequent blood samples are drawn at specific intervals, typically at 4 hours and 8 hours post-administration.
All samples must be processed consistently to measure serum cortisol concentrations accurately.
Interpreting the Results Table
The diagnostic value of the LDDST is crystallized in the data it produces. Interpretation relies on comparing the cortisol levels at the 4-hour and 8-hour marks against the baseline and established suppression criteria. The table below illustrates the typical patterns a veterinary professional will analyze:
